Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642382 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle Osteoarthritis
A NA study, sponsored by Cartiva.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00642382 is a NA study that was terminated before completion, run by Cartiva. The registered enrollment target is 17 participants.
The verdict
NCT00642382, a NA study, was terminated before completion, sponsored by Cartiva.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Agilus is safe and effective in the treatment of mild to moderate ankle osteoarthritis.
Interventions
- DEVICE Agilus
- DEVICE Normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00642382
The ClinicalTrials.gov registry entry for NCT00642382 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cartiva, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Agilus is the first listed.
NCT00642382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00642382 about?
NCT00642382 is a clinical study titled "Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle Osteoarthritis". The purpose of this study is to determine whether Agilus is safe and effective in the treatment of mild to moderate ankle osteoarthritis.
What is the current status of trial NCT00642382?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2008-04. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00642382?
The interventions under investigation include: Agilus (DEVICE), Normal saline (DEVICE).
Who is sponsoring clinical trial NCT00642382?
This trial is sponsored by Cartiva, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.